Financhill
Back

Can Fite Biofarma Stock Predictions

Can Fite Biofarma Stock Forecast

  • Is Can Fite Biofarma Stock Undervalued?
    The current Can Fite Biofarma [CANF] share price is $2.01. The Score for CANF is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • CANF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Can Fite Biofarma Stock Go Up Next Year?

Data Unavailable

Can Fite Biofarma Stock Rating

Data Unavailable

Can Fite Biofarma Stock Price History

Is CANF stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CANF is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NYAM
Country:
Israel
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
canfite.com

52-Week Data

52-Week High:
4.69
52-Week Low:
1.83

Prediction Charts

Market Cap:
12.25M
Price in USD:
2.01
Volume:
95.51K
Beta:
1.52

Technical Analysis

SMA50:
2.23
SMA100:
2.53
SMA200:
2.40
52-Wk Change:
0.25%

Stock Predictions

  • Is Can Fite Biofarma stock public?
    Yes, Can Fite Biofarma is a publicly traded company.
  • What is the Can Fite Biofarma stock quote today?
    The Can Fite Biofarma stock price is 2.01 USD today.
  • How to buy Can Fite Biofarma stock online?
    You can buy Can Fite Biofarma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-1 2.20 2.16 2.25 2.04
Nov-4 2.19 2.15 2.50 2.07
Nov-5 2.19 2.19 2.28 2.10
Nov-6 2.20 2.19 2.25 2.04
Nov-7 2.18 2.05 2.38 2.05
Nov-8 2.11 2.12 2.19 2.05
Nov-11 2.13 2.11 2.22 2.09
Nov-12 2.14 2.08 2.20 2.03
Nov-13 2.11 2.07 2.21 2.03
Nov-14 2.09 1.99 2.14 1.98
Nov-15 1.99 1.96 2.08 1.93
Nov-18 2.03 2.00 2.11 1.99
Nov-19 2.03 2.03 2.11 1.96
Nov-20 2.09 2.01 2.09 1.90

Can Fite Biofarma Earnings

Data Unavailable

Can Fite Biofarma Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and a decrease next year of $0.10 per share.

* Can Fite Biofarma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.